Table 3.
The clinical features of patients with BRAF V600E mutation
| No. | Gender | Age | Smoking | TNM stage |
Blood BRAF |
Blood EGFR |
Tissue EGFR |
|---|---|---|---|---|---|---|---|
| 1 | F | 80 | 1 | II | 1 | 1 | 0 |
| 2 | M | 80 | 1 | IV | 1 | 0 | 0 |
| 3 | M | 58 | 1 | IV | 1 | 0 | 0 |
| 4 | F | 65 | 0 | IV | 0 | 0 | 1 |
| 5 | F | 61 | 0 | IV | 0 | 0 | 1 |
| 6 | F | 79 | 0 | IV | – | – | 0 |
| 7 | F | 73 | 0 | IIIa | – | – | 0 |
| 8 | F | 57 | 0 | IV | – | – | 1 |
BRAF, v-raf murine sarcoma viral oncogene homolog B; EGFR, epidermal growth factor receptor; TNM, tumor node metastasis.